Cytarabine-induced corneal toxicity [19]

Eye

Volumn 17, Issue 5, 2003, Pages 677-678

  Lochhead, Jon ^a   Salmon, J F ^a   Bron, A J ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BLEPHAROSPASM; CASE REPORT; CONJUNCTIVA DISEASE; CORNEA DISEASE; HUMAN; LETTER; LOW DRUG DOSE; MALE; PHOTOPHOBIA; STEROID THERAPY; SYMPTOMATOLOGY; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

EID: 0042168828     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700451     Document Type: Letter

References (5)

1. Hopen G, Mondino BJ, Johnson BL, Chevernick PA. Corneal toxicity with systemic cytarabine. Am J Ophthalmol 1981; 91: 500-504.
2. Lass JH, Lazarus HM, Reed MD, Herzig RH. Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol 1982; 94: 617-621.
3. Kumar L, Dua H, Agarwal S, Singh S, Kochupillai V. Ocular toxicity of low dose cytosar. New Zealand Med J 1987; 100: 361.
4. Barletta J, Fanous M, Margo C. Corneal and conjunctival toxicity with low-dose cytosine arabinoside. Am J Ophthalmol 1992; 113: 587-588.
5. Lauweryns B, van den Oord JJ, Missotten L. The transitional zone between limbus and peripheral cornea. An immunohistochemical study. Invest Ophthalmol Vis Sci 1993; 34: 1991-1999.